image
Haemonetics Corporation HAE
Healthcare - Medical - Instruments & Supplies - NYSE - US
Watchlist
$ 66.92
-2.89 %
$ 3.36 B
Market Cap
20.22
P/E
INCOME STATEMENT
1.36 B REVENUE
3.95%
Growth Rates
1Year 3.95%
3Years 11.07%
5Years 6.60%
7Years 6.02%
10Years 4.10%
222 M OPERATING INCOME
34.53%
Growth Rates
1Year 34.53%
3Years 40.05%
5Years 7.58%
7Years 21.68%
10Years 18.53%
168 M NET INCOME
42.64%
Growth Rates
1Year 42.64%
3Years 56.94%
5Years 16.99%
7Years 20.46%
10Years 25.80%
EFFICIENCY
Earnings Waterfall Haemonetics Corporation
image
Revenue 1.36 B
Cost Of Revenue 612 M
Gross Profit 749 M
Operating Expenses 527 M
Operating Income 222 M
Other Expenses 54.1 M
Net Income 168 M
1b1b1b1b1b1b800m800m600m600m400m400m200m200m001b(612m)749m(527m)222m(54m)168mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Mar-2025 Mar-2024 Apr-2023 Apr-2022 Apr-2021 Mar-2020 Mar-2019 Mar-2018 Apr-2017 Apr-2016 Mar-2015 Mar-2014 Mar-2013 Mar-2012 Apr-2011 Apr-2010 Mar-2009 Mar-2008 Mar-2007 Apr-2006 Apr-2005 Apr-2004 Mar-2003 Mar-2002 Mar-2001 Apr-2000 Apr-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992 Mar-1991
REVENUE
Revenue 1 360.8 1 309.1 1 168.7 993.2 870.5 988.5 967.6 903.9 886.1 909.7 910.4 938.5 892.0 727.8 676.7 645.4 597.9 516.4 449.6 419.7 383.6 364.2 337.0 320.0 293.9 277.9 282.1 285.8 309.8 278.2 262.4 248.4 216.3 176.4 157.3
GROSS PROFIT
Cost Of Revenue 611.9 617.5 553.6 487.7 472.6 504.0 550.0 492.0 507.6 503.8 476.0 470.1 463.9 358.6 321.5 307.9 289.7 258.7 222.3 199.2 185.7 192.1 182.3 165.1 126.9 121.7 124.0 127.1 137.8 110.5 103.9 94.2 88.8 78.5 0
Gross Profit 749.0 691.5 615.1 505.5 397.8 484.5 417.5 411.9 378.5 405.9 434.4 468.4 428.1 369.2 355.2 337.5 308.2 257.7 227.3 220.5 197.9 172.1 154.7 154.8 166.9 156.2 158.1 158.7 172.0 167.7 158.5 154.2 127.5 97.9 157.3
OPERATING INCOME
Operating Expenses 527.1 526.7 459.1 433.8 339.9 330.6 334.0 355.8 339.3 369.5 393.9 421.0 367.4 282.1 244.7 240.9 222.6 187.4 155.5 121.5 137.9 126.2 117.2 108.4 110.4 122.6 126.4 127.7 123.6 113.4 106.1 102.4 85.7 68.0 0
Selling, General and Administrative Expenses 436.8 431.8 376.7 339.6 274.2 299.7 298.3 316.5 301.7 324.0 339.7 366.8 318.8 245.3 213.9 214.5 198.7 163.1 137.1 121.4 118.0 108.5 97.7 88.9 86.7 82.8 86.7 86.9 92.3 81.8 75.7 75.9 77.2 61.0 0
Research and Development Expenses 62.7 54.4 50.1 46.8 32.9 30.9 35.7 39.2 37.6 45.6 54.2 54.2 48.6 36.8 32.7 26.4 23.9 24.3 23.9 26.5 20.0 17.8 19.5 19.5 19.0 14.9 15.1 17.9 19.0 18.5 16.7 15.8 0 0 0
Operating Income 221.8 164.9 156.0 80.8 58.0 153.9 83.5 56.2 (19.4) (44.0) 40.5 47.3 56.4 88.8 110.5 83.3 85.6 70.3 62.7 99.0 59.9 45.9 37.5 36.4 13.4 33.6 31.7 31.0 48.4 54.3 52.4 51.8 41.8 29.9 157.3
PRE-TAX INCOME
Interest Income Expense (9.7) 13.0 14.6 17.1 16.8 16.2 9.9 4.5 8.1 9.5 9.4 10.9 6.5 0 6 K 0.7 64 K 0 97 K 0 0 0 0 13.6 59.4 13.1 0 74.9 0 0 0 0 1.6 1.6 0
Total Other Income (9.7) (55.0) (14.6) (17.1) 14.9 (16.2) (9.9) 3.5 (8.1) (97.1) (9.4) (10.9) (6.5) 0.7 (0.5) (2.0) (0.6) 7.0 9.6 7.9 (0.1) 65 K 1.1 2.1 3.9 3.3 1.0 (26.5) 2.3 0.9 100 K (1.0) (1.8) (2.2) (157.3)
Pre-Tax Income 212.1 151.9 141.4 63.6 72.9 87.2 73.6 59.6 (27.5) (53.5) 31.2 36.4 49.9 89.5 110.1 81.3 85.0 77.3 72.3 106.9 59.8 45.8 38.6 38.5 17.3 27.3 32.6 4.5 50.7 55.2 52.5 50.8 40.0 27.7 0
NET INCOME
Tax Provision 44.4 34.3 26.0 20.3 (6.6) 10.6 18.6 14.1 (1.2) 2.2 14.3 1.3 11.1 22.6 30.1 22.9 25.7 25.3 23.2 37.8 20.2 16.5 10.2 10.8 10.1 8.5 11.4 3.9 17.7 19.3 18.9 19.3 15.2 9.7 0
Net Income 167.7 117.6 115.4 43.4 79.5 76.5 55.0 45.6 (26.3) (55.6) 16.9 35.1 38.8 66.9 80.0 58.4 59.3 52.0 49.1 69.1 39.6 29.3 28.4 30.0 7.2 19.0 21.1 (24.8) 33.0 35.9 33.6 31.5 24.8 18.0 0
EPS 3.31 2.32 2.27 0.85 1.57 1.51 1.07 0.86 0.51 1.09 0.33 0.68 0.76 1.3 1.59 1.15 1.17 1 0.92 1.29 0.77 0.6 0.57 0.57 0.14 0.3 0.39 0.47 0.61 0.66 0.61 0.56 0.45 0.33 0.26